D
Diane L. Tribble
Researcher at Stanford University
Publications - 12
Citations - 5148
Diane L. Tribble is an academic researcher from Stanford University. The author has contributed to research in topics: Lipoprotein & Apolipoprotein B. The author has an hindex of 8, co-authored 12 publications receiving 5049 citations. Previous affiliations of Diane L. Tribble include University of California, Berkeley.
Papers
More filters
Journal ArticleDOI
AHA Dietary Guidelines Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association
Ronald M. Krauss,Robert H. Eckel,Barbara V. Howard,Lawrence J. Appel,Stephen R. Daniels,Richard J. Deckelbaum,John W. Erdman,Penny M. Kris-Etherton,Ira J. Goldberg,Theodore A. Kotchen,Alice H. Lichtenstein,William E. Mitch,Rebecca M. Mullis,Killian Robinson,Judith Wylie-Rosett,Sachiko T. St. Jeor,John Suttie,Diane L. Tribble,Terry L. Bazzarre +18 more
TL;DR: In this paper, the authors present guidelines for reducing the risk of cardiovascular disease by dietary and other lifestyle practices, which place increased emphasis on foods and an overall eating pattern and the need for all Americans to achieve and maintain a healthy body weight.
Journal ArticleDOI
AHA Dietary Guidelines Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association
Ronald M. Krauss,Robert H. Eckel,Barbara V. Howard,Lawrence J. Appel,Stephen R. Daniels,Richard J. Deckelbaum,John W. Erdman,Penny M. Kris-Etherton,Ira J. Goldberg,Theodore A. Kotchen,Alice H. Lichtenstein,William E. Mitch,Rebecca M. Mullis,Killian Robinson,Judith Wylie-Rosett,Sachiko T. St. Jeor,John Suttie,Diane L. Tribble,Terry L. Bazzarre +18 more
TL;DR: The overall approach has been modified to emphasize their relation to specific goals that the AHA considers of greatest importance for lowering the risk of heart disease and stroke and increased emphasis on foods and an overall eating pattern.
Journal ArticleDOI
Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans
Thomas Sudhop,Dieter Lütjohann,Annette Kodal,Michael Igel,Diane L. Tribble,Sukrut Shah,Inna Perevozskaya,Klaus von Bergmann +7 more
TL;DR: In humans, ezetimibe inhibits cholesterol absorption and promotes a compensatory increase of cholesterol synthesis, followed by clinically relevant reductions in LDL and total cholesterol concentrations.
Journal ArticleDOI
Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B
TL;DR: The increased atherogenic risk associated with the pattern B phenotype may result in part from increased concentrations of lipoprotein subpopulations that are relatively susceptible to oxidative modification.
Oxidative Modification in Subjects With the Atherogenic Lipoprotein Phenotype, Pattern B
TL;DR: In this article, the authors compared six density subfractions of LDL isolated from pattern A and pattern B subjects, and found that the fraction with the major LDL peak had a shorter lag time (p < 0.05) in pattern B than in pattern A.